Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Regeneron Pharmaceuticals is a leading US-based biopharmaceutical company that researches, develops, and markets innovative medicines. It focuses on improving the health of patients with serious diseases through scientific discoveries in areas such as oncology, immunology, and ophthalmology.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Regeneron Pharmaceuticals is scheduled to report its next quarterly earnings on 10/29/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Regeneron Pharmaceuticals last reported quarterly earnings on 7/30/2026 (Q2 2026). Earnings per share (EPS) came in at 14.29 USD.
Across its last 5 earnings reports, Regeneron Pharmaceuticals stock moved by ±6% on average the following day. The largest reaction was +11.8% on 10/28/2025; 3 of 5 reactions were positive.
Regeneron Pharmaceuticals has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 5 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.